Litigation Details for Galderma Laboratories, L.P. v. Apotex Inc. (D. Del. 2022)
✉ Email this page to a colleague
Galderma Laboratories, L.P. v. Apotex Inc. (D. Del. 2022)
Docket | ⤷ Subscribe | Date Filed | 2022-06-02 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 7,749,532; 8,206,740 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Galderma Laboratories, L.P. v. Apotex Inc.
Details for Galderma Laboratories, L.P. v. Apotex Inc. (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-06-02 | 3 | ANDA Form | Expiration of Patent: December 24, 2025 (U.S. Patent No. 8,206,740), December 19, 2027 (U.S. Patent No. 7,749,532… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 2 June 2022 1:22-cv-00724 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-06-02 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2; 8,206,740 B2. (… 2 June 2022 1:22-cv-00724 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |